Alerts will be sent to your verified email
Verify Email
VALIANTLAB
|
Valiant Laboratories
|
Brooks Laboratories
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.49 % | -23.88 % | 8.49 % |
|
5yr average Equity Multiplier
|
2.04 | 1.78 | 1.47 |
|
5yr Average Asset Turnover Ratio
|
1.23 | 0.6 | 0.58 |
|
5yr Avg Net Profit Margin
|
6.1 % | -23.79 % | 10.0 % |
|
Price to Book
|
2.0 | 4.61 | 2.18 |
|
P/E
|
0.0 | 0.0 | 48.75 |
|
5yr Avg Cash Conversion Cycle
|
77.97 Days | -10.34 Days | 13.14 Days |
|
Inventory Days
|
18.84 Days | 93.5 Days | 66.66 Days |
|
Days Receivable
|
161.25 Days | 66.75 Days | 122.66 Days |
|
Days Payable
|
82.33 Days | 179.8 Days | 257.34 Days |
|
5yr Average Interest Coverage Ratio
|
44.93 | -11.84 | 10.36 |
|
5yr Avg ROCE
|
18.33 % | -15.03 % | 12.12 % |
|
5yr Avg Operating Profit Margin
|
6.8 % | -13.23 % | 16.84 % |
|
5 yr average Debt to Equity
|
0.59 | 0.21 | 0.14 |
|
5yr CAGR Net Profit
|
n/a | 0.22 % | -6.51 % |
|
5yr Average Return on Assets
|
9.61 % | -14.62 % | 5.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.94 % | 52.62 % | 40.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -13.79 % | -3.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 9.9 % | 0.0 |
|
Valiant Laboratories
|
Brooks Laboratories
|
Medicamen Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|